S100A8/A9 Inhibition Reduces Splenic Myelopoiesis and Improves Outcomes After Stroke
Hyun Ah Kim, Annas Al‐Sharea, Hannah X. Chu, Sung‐Chun Tang, Samoda Rupasinghe, Shenpeng R. Zhang, Prabhakara R. Nagareddy, Grant Raymond Drummond, Thiruma Valavan Arumugam, Andrew James Murphy, Christopher Graeme Sobey, Man K.S. Lee
This study shows that S100A8/A9 inhibition reduces splenic myelopoiesis and improves stroke outcomes by decreasing neutrophilia and infarct size.
Frontiers in Immunology · Feb 17, 2026Peer-reviewedNeuroscience